Dynamic Risk Assessment Using Unstimulated Serum Thyroglobulin Level and Thyroglobulin Doubling Rate after Total Thyroidectomy for Papillary Thyroid Carcinoma
Open Access
- 11 August 2025
- journal article
- Published by SAGE Publications in Thyroid®
- Vol. 35 (10) , 1153-1161
Abstract
Background: Thyroglobulin (Tg), stimulated or unstimulated by recombinant human thyrotropin (TSH), is a static marker of recurrent or persistent disease, and the Tg-doubling rate (Tg-DR) is a dynamic prognostic factor. This study evaluated the prognostic value of an unstimulated Tg (uTg) and Tg-DR papillary thyroid carcinoma (PTC). Methods: This retrospective study included 1818 Tg antibody (Tg-Ab)-negative patients who underwent curative intent total thyroidectomy for PTC without distant metastasis. The uTg was measured 1–3 months post-surgery under TSH suppression (p < 0.001). We divided 1212 patients with no adjuvant radioactive iodine treatment, of whom uTg and Tg-DR data were available, into four categories A, uTg ≥3 ng/mL and Tg-DR ≥0.33/year; B, uTg p < 0.001, hazard ratio or HR [CI]: 5.083 [1.994–12.955]; B vs. C, p = 0.001, HR [CI]: 2.654 [1.462–4.824]; C vs. D, p < 0.001, HR [CI]: 27.420 [15.100–4.980]). The distant recurrence-free survival rate (DR-FS) of category B did not differ from that of category C ( p = 0.419), but DR-FS of category D was better ( p < 0.001) than those of B and C, and that of category A tended to be worse ( p = 0.087) compared with those of B and C. Patients in category A, categories B and C, and category D could thus be classified as high-risk, intermediate-risk, and low-risk for distant recurrence, respectively. Conclusions: This study demonstrates the prognostic value of postoperative uTg and Tg-DR in Tg-Ab-negative patients with PTC under TSH suppression after total thyroidectomy. Prospective studies are needed to confirm these findings.Keywords
This publication has 14 references indexed in Scilit:
- A high Ki‐67 labeling index and high thyroglobulin doubling rate are significant predictors of excision‐site recurrence of papillary thyroid carcinoma following airway resection for locally curative surgeryWorld Journal of Surgery, 2024
- Differentiated Thyroid Carcinoma Long‐Term Prognostic FactorsInternational Journal of Surgical Oncology, 2024
- The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinomaBMC Surgery, 2022
- Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodineNuclear Medicine Communications, 2020
- Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentationSurgery, 2019
- Serum Thyroglobulin Doubling Time in Progressive Thyroid CancerThyroid®, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Ki-67 Labeling Index Is a Predictor of Postoperative Persistent Disease and Cancer Growth and a Prognostic Indicator in Papillary Thyroid CarcinomaEuropean Thyroid Journal, 2013
- Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total ThyroidectomyThyroid®, 2011
- A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up periodSurgery, 2004